These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 21875382)

  • 1. Detection and characterization of ZnT8 autoantibodies could help to screen latent autoimmune diabetes in adult-onset patients with type 2 phenotype.
    Trabucchi A; Faccinetti NI; Guerra LL; Puchulu FM; Frechtel GD; Poskus E; Valdez SN
    Autoimmunity; 2012 Mar; 45(2):137-42. PubMed ID: 21875382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of ZnT8 antibody in relation to phenotype and SLC30A8 polymorphism in adult autoimmune diabetes: results from the HUNT study, Norway.
    Sørgjerd EP; Skorpen F; Kvaløy K; Midthjell K; Grill V
    Autoimmunity; 2013 Feb; 46(1):74-9. PubMed ID: 23061550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of zinc transporter 8 (ZnT8) antibodies in autoimmune diabetic patients from Argentinian population using monomeric, homodimeric, and heterodimeric ZnT8 antigen variants.
    Faccinetti NI; Guerra LL; Penas Steinhardt A; Iacono RF; Frechtel GD; Trifone L; Poskus E; Trabucchi A; Valdez SN
    Eur J Endocrinol; 2016 Feb; 174(2):157-65. PubMed ID: 26567119
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zinc transporter type 8 autoantibodies (ZnT8A): prevalence and phenotypic associations in latent autoimmune diabetes patients and patients with adult onset type 1 diabetes.
    Andersen MK; Härkönen T; Forsblom C; Groop PH; Knip M; Tuomi T
    Autoimmunity; 2013 Jun; 46(4):251-8. PubMed ID: 23194113
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Zinc transporter 8 autoantibody (ZnT8A) could help differentiate latent autoimmune diabetes in adults (LADA) from phenotypic type 2 diabetes mellitus.
    Huang G; Xiang Y; Pan L; Li X; Luo S; Zhou Z
    Diabetes Metab Res Rev; 2013 Jul; 29(5):363-8. PubMed ID: 23390067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Are zinc transporter type 8 antibodies a marker of autoimmune thyroiditis in non-obese adults with new-onset diabetes?
    Rogowicz-Frontczak A; Zozuliłska-Ziołkiewicz D; Litwinowicz M; Niedźwiecki P; Wyka K; Wierusz-Wysocka B
    Eur J Endocrinol; 2014 Apr; 170(4):651-8. PubMed ID: 24480135
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnostic value of zinc transporter 8 autoantibody (ZnT8A) for type 1 diabetes in Chinese.
    Yang L; Luo S; Huang G; Peng J; Li X; Yan X; Lin J; Wenzlau JM; Davidson HW; Hutton JC; Zhou Z
    Diabetes Metab Res Rev; 2010 Oct; 26(7):579-84. PubMed ID: 20842762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to insulin, insulinoma-associated antigen-2, and zinc transporter 8 improve the prediction of early insulin requirement in adult-onset autoimmune diabetes.
    Kawasaki E; Nakamura K; Kuriya G; Satoh T; Kuwahara H; Kobayashi M; Abiru N; Yamasaki H; Eguchi K
    J Clin Endocrinol Metab; 2010 Feb; 95(2):707-13. PubMed ID: 20061424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Positive autoantibodies to ZnT8 indicate elevated risk for additional autoimmune conditions in patients with Addison's disease.
    Fichna M; Rogowicz-Frontczak A; Żurawek M; Fichna P; Gryczyńska M; Zozulińska-Ziółkiewicz D; Ruchała M
    Endocrine; 2016 Jul; 53(1):249-57. PubMed ID: 26972575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutamic acid decarboxylase autoantibodies are dominant but insufficient to identify most Chinese with adult-onset non-insulin requiring autoimmune diabetes: LADA China study 5.
    Xiang Y; Huang G; Shan Z; Pan L; Luo S; Yang L; Shi L; Li Q; Leslie RD; Zhou Z
    Acta Diabetol; 2015 Dec; 52(6):1121-7. PubMed ID: 26239144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of tyrosine phosphatase 2(256-760) construct as a new, sensitive marker for the detection of islet autoimmunity in type 2 diabetic patients: the non-insulin requiring autoimmune diabetes (NIRAD) study 2.
    Tiberti C; Giordano C; Locatelli M; Bosi E; Bottazzo GF; Buzzetti R; Cucinotta D; Galluzzo A; Falorni A; Dotta F
    Diabetes; 2008 May; 57(5):1276-83. PubMed ID: 18332100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of the post-onset decline in zinc transporter 8 autoantibodies in type 1 diabetic human subjects.
    Wenzlau JM; Walter M; Gardner TJ; Frisch LM; Yu L; Eisenbarth GS; Ziegler AG; Davidson HW; Hutton JC
    J Clin Endocrinol Metab; 2010 Oct; 95(10):4712-9. PubMed ID: 20610599
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carboxypeptidase-H autoantibodies differentiate a more latent subset of autoimmune diabetes from phenotypic type 2 diabetes among Chinese adults.
    Yang L; Zhou ZG; Tan SZ; Huang G; Jin P; Yan X; Li X; Peng H; Hagopian W
    Ann N Y Acad Sci; 2008 Dec; 1150():263-6. PubMed ID: 19120309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel enzyme-linked immunosorbent assay for bivalent ZnT8 autoantibodies.
    Kawasaki E; Tanaka M; Miwa M; Abiru N; Kawakami A
    Acta Diabetol; 2014; 51(3):429-34. PubMed ID: 24292540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlations between islet autoantibody specificity and the SLC30A8 genotype with HLA-DQB1 and metabolic control in new onset type 1 diabetes.
    Brorsson C; Vaziri-Sani F; Bergholdt R; Eising S; Nilsson A; Svensson J; Lernmark Å; Pociot F;
    Autoimmunity; 2011 Mar; 44(2):107-14. PubMed ID: 20836749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bridging-type enzyme-linked immunoassay for zinc transporter 8 autoantibody measurements in adult patients with diabetes mellitus.
    Dunseath G; Ananieva-Jordanova R; Coles R; Powell M; Amoroso M; Furmaniak J; Smith BR; Dayan C; Luzio S
    Clin Chim Acta; 2015 Jul; 447():90-5. PubMed ID: 26006309
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Screening for insulinoma antigen 2 and zinc transporter 8 autoantibodies: a cost-effective and age-independent strategy to identify rapid progressors to clinical onset among relatives of type 1 diabetic patients.
    Gorus FK; Balti EV; Vermeulen I; Demeester S; Van Dalem A; Costa O; Dorchy H; Tenoutasse S; Mouraux T; De Block C; Gillard P; Decochez K; Wenzlau JM; Hutton JC; Pipeleers DG; Weets I;
    Clin Exp Immunol; 2013 Jan; 171(1):82-90. PubMed ID: 23199327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive power of screening for antibodies against insulinoma-associated protein 2 beta (IA-2beta) and zinc transporter-8 to select first-degree relatives of type 1 diabetic patients with risk of rapid progression to clinical onset of the disease: implications for prevention trials.
    De Grijse J; Asanghanwa M; Nouthe B; Albrecher N; Goubert P; Vermeulen I; Van Der Meeren S; Decochez K; Weets I; Keymeulen B; Lampasona V; Wenzlau J; Hutton JC; Pipeleers D; Gorus FK;
    Diabetologia; 2010 Mar; 53(3):517-24. PubMed ID: 20091020
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies against zinc transporter 8 are related to age, metabolic state and HLA DR genotype in children with newly diagnosed type 1 diabetes.
    Salonen KM; Ryhänen S; Härkönen T; Ilonen J; Knip M;
    Diabetes Metab Res Rev; 2013 Nov; 29(8):646-54. PubMed ID: 23861236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zinc transporter 8 autoantibodies assessment in daily practice.
    Hussein H; Ibrahim F; Sobngwi E; Gautier JF; Boudou P
    Clin Biochem; 2017 Jan; 50(1-2):94-96. PubMed ID: 27363941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.